![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
China Med | LSE:CMDS | London | Ordinary Share | SG9999002489 | ORD NPV (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 57.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
CHINA MEDSTAR LIMITED Enhanced Funding Arrangement China Medstar Limited ("Medstar" or the "Company"), specialist in the supply of diagnostic imaging and radiotherapy equipment to medical centres in hospitals in China, announces it has received approval for a Finance Lease Licence (the "Licence") from the government of the People's Republic of China. The Company announced in its interim results last September that it had submitted an application and today's successful outcome means the availability of further potential business opportunities for Medstar. This will be driven by an enlarged range of funding options to those hospitals who wish to either purchase equipment or open cancer treatment centres in partnership with Medstar. To date, the Company has generated revenues through its Equipment Leasing Division from operating leases through profit share agreements with hospitals. The Licence allows the Company to expand its service offerings to include both short and long term finance leases to hospitals or a fixed minimum payment plus profit sharing arrangement. A principal benefit of this Licence is that the Company may now enter into agreements with hospitals where the regional government will only permit finance leases as a means of capital investment. Dr. Cheng Zheng, Chairman and CEO, commented: "Today's development will enable us to compete in the previously untouched financing market and should provide a number of future opportunities. The Directors are confident that this strengthened financing position will lead to further contracts and a broadening of the overall business strategy. "We plan to increase our market share over the next six months while continually improving our operational position." 8 November 2007 Enquiries: China Medstar Ltd Tel: +86 (10) 5825 6867 Dr Cheng Zheng, Chairman and CEO/ Yap Yaw Kong, CFO Evolution Securities Tel: +44 (0) 20 7071 4300 Tom Price/Bobbie Hilliam Evolution Securities China Tel: +44 (0) 20 7220 4850 Nick Martin Nexus Financial Ltd Tel: +44 (0) 20 7451 7050 Nicholas Nelson/Kathy Boate END
1 Year China Med Chart |
1 Month China Med Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions